{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T18:07:32Z","timestamp":1794766052664,"version":"4.9.1"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Organ dysfunction is a key feature of cardiogenic shock. Active revascularization and contemporary management in intensive care has improved prognosis in cardiogenic shock, but mortality is still unacceptably high. This review will discuss the prevalence, manifestation, management and clinical impact of kidney and liver dysfunction in cardiogenic shock.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Patients with cardiogenic shock more frequently have several comorbidities that make them at risk of developing multiorgan failure, including renal and liver dysfunction. Kidney and liver injury and dysfunction will markedly increase mortality of patients with cardiogenic shock. Management requires active monitoring of organ function and knowledge of criteria for detection and classification of organ injury. The SOFA score for prediction of mortality in the critically ill incorporates organ injury and can be used also in cardiogenic shock, but risk prediction models specific for cardiogenic shock exist. Biomarkers reflecting different pathways activated in cardiogenic shock correlate with severity of organ dysfunction and may improve risk prediction in cardiogenic shock. Preliminary data suggest that they can even be future treatment targets.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Monitoring renal and hepatic function and identifying injury and dysfunction of these organs is essential for the management and mortality risk assessment of patients in cardiogenic shock.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000746","type":"journal-article","created":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T06:49:04Z","timestamp":1591771744000},"page":"417-423","source":"Crossref","is-referenced-by-count":11,"title":["Kidney and liver dysfunction in cardiogenic shock"],"prefix":"10.1097","volume":"26","author":[{"given":"Johan","family":"Lassus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,6,9]]},"reference":[{"key":"R1-20231211","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1161\/CIR.0000000000000525","article-title":"Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association","volume":"136","author":"van Diepen","year":"2017","journal-title":"Circulation"},{"key":"R2-20231211","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R3-20231211","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"R4-20231211","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1710261","article-title":"PCI strategies in patients with acute myocardial infarction and cardiogenic shock","volume":"377","author":"Thiele","year":"2017","journal-title":"N Engl J Med"},{"key":"R5-20231211","doi-asserted-by":"crossref","first-page":"e000590","DOI":"10.1161\/JAHA.113.000590","article-title":"Trends in incidence, management, and outcomes of cardiogenic shock complicating ST-elevation myocardial infarction in the United States","volume":"3","author":"Kolte","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R6-20231211","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/ejhf.646","article-title":"Cardiogenic shock in intensive care units: evolution of prevalence, patient profile, management and outcomes","volume":"19","author":"Puymirat","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"R7-20231211","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1016\/j.jacc.2019.01.053","article-title":"Acute noncardiac organ failure in acute myocardial infarction with cardiogenic shock","volume":"73","author":"Vallabhajosyula","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R8-20231211","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCC.0000000000000522","article-title":"The modern cardiovascular care unit: the cardiologist managing multiorgan dysfunction","volume":"24","author":"Bochaton","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"R9-20231211","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"R10-20231211","doi-asserted-by":"crossref","first-page":"e005618","DOI":"10.1161\/CIRCOUTCOMES.119.005618","article-title":"Epidemiology of shock in contemporary cardiac intensive care units","volume":"12","author":"Berg","year":"2019","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R11-20231211","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1681\/ASN.2006010073","article-title":"Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure","volume":"17","author":"Waikar","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R12-20231211","first-page":"1","article-title":"KDIGO Clinical Practice Guideline for Acute Kidney Injury","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"R13-20231211","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/ejhf.958","article-title":"Acute kidney injury in cardiogenic shock: definitions, incidence, haemodynamic alterations, and mortality","volume":"20","author":"Tarvasmaki","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"R14-20231211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcrc.2018.11.004","article-title":"Risk indicators for acute kidney injury in cardiogenic shock","volume":"50","author":"van den Akker","year":"2019","journal-title":"J Crit Care"},{"key":"R15-20231211","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/ejhf.1032","article-title":"Acute kidney injury in cardiogenic shock: in search of early detection and clinical certainty","volume":"20","author":"Afzal","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"R16-20231211","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"R17-20231211","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function: measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"R18-20231211","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/ejhf.872","article-title":"Organ dysfunction, injury and failure in acute heart failure: from pathophysiology to diagnosis and management. A review on behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)","volume":"19","author":"Harjola","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"R19-20231211","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinchem\/26.9.1241","article-title":"Serum enzymes and isoenzymes in the diagnosis and differential diagnosis of myocardial ischemia and necrosis","volume":"26","author":"Lott","year":"1980","journal-title":"Clin Chem"},{"key":"R20-20231211","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0140-6736(10)60274-7","article-title":"Acute liver failure","volume":"376","author":"Bernal","year":"2010","journal-title":"Lancet"},{"key":"R21-20231211","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.cld.2018.01.001","article-title":"Classification and epidemiologic aspects of acute liver failure","volume":"22","author":"Pievsky","year":"2018","journal-title":"Clin Liver Dis"},{"key":"R22-20231211","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00392-016-1060-3","article-title":"Incidence, laboratory detection and prognostic relevance of hypoxic hepatitis in cardiogenic shock","volume":"106","author":"Jung","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"R23-20231211","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.amjcard.2017.06.049","article-title":"Frequency and prognostic significance of abnormal liver function tests in patients with cardiogenic shock","volume":"120","author":"Jantti","year":"2017","journal-title":"Am J Cardiol"},{"key":"R24-20231211","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ijcard.2015.04.242","article-title":"Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial","volume":"191","author":"Fuernau","year":"2015","journal-title":"Int J Cardiol"},{"key":"R25-20231211","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/CCM.0b013e3181b9eb3b","article-title":"Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission","volume":"38","author":"Marenzi","year":"2010","journal-title":"Crit Care Med"},{"key":"R26-20231211","doi-asserted-by":"crossref","first-page":"e0222894","DOI":"10.1371\/journal.pone.0222894","article-title":"Temporal trends, predictors, and outcomes of acute kidney injury and hemodialysis use in acute myocardial infarction-related cardiogenic shock","volume":"14","author":"Vallabhajosyula","year":"2019","journal-title":"PLoS One"},{"key":"R27-20231211","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.amjcard.2019.02.038","article-title":"Characteristics and outcomes of patients with cardiogenic shock utilizing hemodialysis for acute kidney injury","volume":"123","author":"Adegbala","year":"2019","journal-title":"Am J Cardiol"},{"key":"R28-20231211","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jchf.2018.12.007","article-title":"Cardiogenic shock in takotsubo cardiomyopathy versus acute myocardial infarction: an 8-year National Perspective on Clinical Characteristics, Management, and Outcomes","volume":"7","author":"Vallabhajosyula","year":"2019","journal-title":"JACC Heart Fail"},{"key":"R29-20231211","doi-asserted-by":"crossref","first-page":"e0217006","DOI":"10.1371\/journal.pone.0217006","article-title":"Hypoalbuminemia is a frequent marker of increased mortality in cardiogenic shock","volume":"14","author":"Jantti","year":"2019","journal-title":"PLoS One"},{"key":"R30-20231211","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/SHK.0000000000001353","article-title":"Serum lactate and a relative change in lactate as predictors of mortality in patients with cardiogenic shock: results from the Cardshock study","volume":"53","author":"Lindholm","year":"2020","journal-title":"Shock"},{"key":"R31-20231211","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MCC.0000000000000632","article-title":"Inotropes and vasopressors use in cardiogenic shock: when, which and how much?","volume":"25","author":"Levy","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"R32-20231211","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s13054-016-1387-1","article-title":"Current real-life use of vasopressors and inotropes in cardiogenic shock: adrenaline use is associated with excess organ injury and mortality","volume":"20","author":"Tarvasmaki","year":"2016","journal-title":"Crit Care"},{"key":"R33-20231211","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R34-20231211","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00134-018-5222-9","article-title":"Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients","volume":"44","author":"Leopold","year":"2018","journal-title":"Intensive Care Med"},{"key":"R35-20231211","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Guideline Work Group. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1)","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"key":"R36-20231211","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.chest.2019.04.004","article-title":"Fluid management in acute kidney injury","volume":"156","author":"Ostermann","year":"2019","journal-title":"Chest"},{"key":"R37-20231211","doi-asserted-by":"crossref","first-page":"R207","DOI":"10.1186\/cc13015","article-title":"Development and standardization of a furosemide stress test to predict the severity of acute kidney injury","volume":"17","author":"Chawla","year":"2013","journal-title":"Crit Care"},{"key":"R38-20231211","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1681\/ASN.2014060535","article-title":"Furosemide stress test and biomarkers for the prediction of AKI severity","volume":"26","author":"Koyner","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R39-20231211","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcrc.2019.04.011","article-title":"The furosemide stress test for prediction of worsening acute kidney injury in critically ill patients: a multicenter, prospective, observational study","volume":"52","author":"Rewa","year":"2019","journal-title":"J Crit Care"},{"key":"R40-20231211","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2048872617702505","article-title":"Altered mental status predicts mortality in cardiogenic shock: results from the CardShock study","volume":"7","author":"Kataja","year":"2018","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"R41-20231211","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008169","article-title":"Predictive value of the sequential organ failure assessment score for mortality in a contemporary cardiac intensive care unit population","volume":"7","author":"Jentzer","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R42-20231211","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.jacc.2017.02.027","article-title":"Risk stratification for patients in cardiogenic shock after acute myocardial infarction","volume":"69","author":"Poss","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"R43-20231211","first-page":"885066619878125","article-title":"Comparative prognostic accuracy of risk prediction models for cardiogenic shock","author":"Miller","year":"2019","journal-title":"J Intensive Care Med"},{"key":"R44-20231211","doi-asserted-by":"crossref","first-page":"e666","DOI":"10.1097\/CCM.0000000000002336","article-title":"Combined measurement of soluble ST2 and amino-terminal Pro-B-type natriuretic peptide provides early assessment of severity in cardiogenic shock complicating acute coronary syndrome","volume":"45","author":"Tolppanen","year":"2017","journal-title":"Crit Care Med"},{"key":"R45-20231211","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13613-016-0229-2","article-title":"Adrenomedullin: a marker of impaired hemodynamics, organ dysfunction, and poor prognosis in cardiogenic shock","volume":"7","author":"Tolppanen","year":"2017","journal-title":"Ann Intensive Care"},{"key":"R46-20231211","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13054-018-1945-9","article-title":"Back-to-back comparison of penKID with NephroCheck(R) to predict acute kidney injury at admission in intensive care unit: a brief report","volume":"22","author":"Gayat","year":"2018","journal-title":"Crit Care"},{"key":"R47-20231211","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.cardfail.2019.07.003","article-title":"Levels of growth differentiation factor 15 and early mortality risk stratification in cardiogenic shock","volume":"25","author":"Hongisto","year":"2019","journal-title":"J Card Fail"},{"key":"R48-20231211","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ejhf.1600","article-title":"Circulating dipeptidyl peptidase 3 and alteration in haemodynamics in cardiogenic shock: results from the OptimaCC trial","volume":"22","author":"Takagi","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R49-20231211","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/CCM.0000000000004044","article-title":"Bioactive adrenomedullin, organ support therapies, and survival in the critically ill: results from the French and European Outcome Registry in ICU study","volume":"48","author":"Lemasle","year":"2020","journal-title":"Crit Care Med"},{"key":"R50-20231211","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jacbts.2019.06.005","article-title":"Acute kidney injury induces remote cardiac damage and dysfunction through the galectin-3 pathway","volume":"4","author":"Prud\u2019homme","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"R51-20231211","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/ejhf.1601","article-title":"Circulating dipeptidyl peptidase 3 is a myocardial depressant factor: dipeptidyl peptidase 3 inhibition rapidly and sustainably improves haemodynamics","volume":"22","author":"Deniau","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"R52-20231211","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s40635-019-0255-0","article-title":"Adrecizumab, a nonneutralizing antiadrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats","volume":"7","author":"Blet","year":"2019","journal-title":"Intensive Care Med Exp"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000746","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T08:06:12Z","timestamp":1702281972000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,9]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000746","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,9]]}}}